Metabolomics and the pig model reveal aberrant cardiac energy metabolism in metabolic syndrome

Maryam Karimi, Victoria Petkova, John M. Asara, Michael J. Griffin, Frank W. Sellke, A. R. Bishop, Boian S. Alexandrov, Anny UshevaScientific 2020 · DOI

Abstract

Although metabolic syndrome (MS) is a significant risk of cardiovascular disease (CVD), the cardiac response (MR) to MS remains unclear due to traditional MS models' narrow scope around a limited number of cell-cycle regulation biomarkers and drawbacks of limited human tissue samples. To date, we developed the most comprehensive platform studying MR to MS in a pig model tightly related to human MS criteria. By incorporating comparative metabolomic, transcriptomic, functional analyses, and unsupervised machine learning (UML), we can discover unknown metabolic pathways connections and links on numerous biomarkers across the MS-associated issues in the heart. For the first time, we show severely diminished availability of glycolytic and citric acid cycle (CAC) pathways metabolites, altered expression, GlcNAcylation, and activity of involved enzymes. A notable exception, however, is the excessive succinate accumulation despite reduced succinate dehydrogenase complex iron-sulfur subunit b (SDHB) expression and decreased content of precursor metabolites. Finally, the expression of metabolites and enzymes from the GABA-glutamate, GABA-putrescine, and the glyoxylate pathways significantly increase, suggesting an alternative cardiac means to replenish succinate and malate in MS. Our platform discovers potential therapeutic targets for MS-associated CVD within pathways that were previously unknown to corelate with the disease.

Introduction

Metabolic syndrome (MS)—a cluster of conditions including obesity, hyperglycemia, and hypertension—is a major precursor to cardiovascular disease (CVD). However, the specific "cross-talk" between metabolic alterations and heart function remains a "black box." Traditional research often relies on small animal models that do not perfectly mimic human heart metabolism, or limited human tissue samples that provide only a partial view. There is a critical need to understand the global metabolic state of the heart under MS stress to identify why the heart eventually fails and how we might intervene.

Methods

The researchers developed a comprehensive platform using a large animal (pig) model that closely recapitulates human MS criteria when fed a high-fat, high-calorie diet. Their approach integrated several high-throughput techniques:

  • Metabolomics: Used LC/MS-MS to quantify 283 polar metabolites in cardiac tissue.
  • Transcriptomics: Performed RNA-Seq to profile global gene expression.
  • Unsupervised Machine Learning (UML): Employed Non-negative Matrix Factorization (NMF) to identify "metabolic signatures" without prior bias.
  • Validation: Confirmed findings using 2D Thin-layer chromatography (2dTLC), Western blotting, and enzymatic activity assays.

Key Results: Phenotype and Histology

Pigs on the MS diet successfully developed all five human diagnostic criteria for MS. A primary indicator was the significant increase in body weight compared to the lean-diet (LD) control group.

Figure 6: Significant weight gain observed in the MS pig model compared to lean-diet controls.

Quantitative histological analysis further confirmed the impact of the MS diet on cardiac tissue. Imaging data revealed a substantial increase in markers associated with tissue remodeling or lipid accumulation, quantified by pixel intensity.

Figure 3: Quantitative histological analysis showing a significant increase in tissue markers in MS hearts compared to LD controls.

Metabolic Rewiring and the "Succinate Paradox"

The study's most striking finding is that the MS heart reroutes its energy production when the standard Citric Acid Cycle (CAC) fails.

  • Alternative Shunts: The heart compensates by upregulating the GABA-glutamate and glyoxylate shunts. These pathways act as "backup generators" to replenish essential intermediates like succinate and malate.
  • The Succinate Paradox: While most intermediates in a failing cycle decrease, the researchers found a massive accumulation of succinate (over 3-fold increase). This suggests a bottleneck where alternative pathways pump succinate into the cycle faster than impaired mitochondrial enzymes can process it.
  • Regulation Beyond Genes: The study highlights that gene expression alone is insufficient to explain metabolic shifts. For example, the enzyme fumarase showed lower activity in MS hearts due to O-GlcNAcylation—a post-translational modification where sugar molecules inhibit protein function.

Conclusion

This platform identifies potential therapeutic targets for MS-associated CVD within pathways that were previously unknown to correlate with the disease. While the current data represents a steady-state snapshot of early-stage MS, future work will focus on metabolic flux and gender-specific responses to develop treatments that can "fix the engine" of the MS heart before permanent damage occurs.

Summary updated

Abstract

Although metabolic syndrome (MS) is a significant risk of cardiovascular disease (CVD), the cardiac response (MR) to MS remains unclear due to traditional MS models' narrow scope around a limited number of cell-cycle regulation biomarkers and drawbacks of limited human tissue samples. To date, we developed the most comprehensive platform studying MR to MS in a pig model tightly related to human MS criteria. By incorporating comparative metabolomic, transcriptomic, functional analyses, and unsupervised machine learning (UML), we can discover unknown metabolic pathways connections and links on numerous biomarkers across the MS-associated issues in the heart. For the first time, we show severely diminished availability of glycolytic and citric acid cycle (CAC) pathways metabolites, altered expression, GlcNAcylation, and activity of involved enzymes. A notable exception, however, is the excessive succinate accumulation despite reduced succinate dehydrogenase complex iron-sulfur subunit b (SDHB) expression and decreased content of precursor metabolites. Finally, the expression of metabolites and enzymes from the GABA-glutamate, GABA-putrescine, and the glyoxylate pathways significantly increase, suggesting an alternative cardiac means to replenish succinate and malate in MS. Our platform discovers potential therapeutic targets for MS-associated CVD within pathways that were previously unknown to corelate with the disease.
BibTeX
@inproceedings{karimi2020metabolomics,
  author = {Maryam Karimi and Victoria Petkova and John M. Asara and Michael J. Griffin and Frank W. Sellke and A. R. Bishop and Boian S. Alexandrov and Anny Usheva},
  title = {{Metabolomics and the pig model reveal aberrant cardiac energy metabolism in metabolic syndrome}},
  booktitle = {Scientific},
  year = {2020},
  doi = {10.1038/s41598-020-60387-7},
}
Figure